# Aelix Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aelix-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Barcelona, Spain
- Website: www.aelixtherapeutics.com
- Total disclosed funding: $12M
- Latest round: Series A (Jan 11, 2016)
- Investors on record: 3

## About

Aelix Therapeutics is a biotechnology firm specializing in vaccine development for chronic viral infections, particularly HIV. The company is dedicated to advancing innovative therapeutic solutions.Aelix Therapeutics focuses on developing vaccines targeting chronic viral infections, including HIV. The company is headquartered in Barcelona, Spain. José Cabero serves as the CEO. In September 2021, Aelix Therapeutics raised EUR 1.9 million in funding to advance its vaccine development efforts, with support from Caixa Capital Risc, Center for Technological & Industrial Development, and Ysios Capital Partners. The total amount raised to date is EUR 1.9 million from two funding rounds.Aelix Therapeutics specializes in developing innovative vaccines aimed at treating chronic viral infections. Their primary focus is on creating safe and effective solutions for diseases like HIV, leveraging advanced biotech methods to enhance immune responses in patients.In 2022, Aelix Therapeutics reported a revenue of EUR 1,270,030.40 with an EBITDA of EUR -695,469.20 for the same year, indicating ongoing investment in research and development activities.Aelix Therapeutics plans to utilize the EUR 1.9 million raised in its latest funding round to further develop its vaccine products. The company is focused on expanding its operations and exploring new markets, particularly within Europe, to reach broader patient populations by 2024. This funding will be pivotal in enhancing their research and accelerating the delivery of their vaccine candidates.

## Funding rounds

- Series A, Jan 11, 2016, $12M — Johnson & Johnson Innovation, Ysios Capital Partners, Caixa Capital Risc

## Investors

- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series A
- Ysios Capital Partners (https://capitalatlas.ai/funds/ysios-capital-partners) — Series A
- Caixa Capital Risc — Series A